Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-3

I skim read through quickly. There is so much going on. I will need a proper read over the weekend.

The FDA expected deadline is still end of 2023. That is fine because right now, PCK have more than enough on their hands trying to grow into other international markets and other sectors like hospice, hospitals, etc.

All in all, a very impressive read given the state of the Covid environment which is not friendly to start up like PCK. For me, the main theme is growth, growth, growth. And more importantly, it is still only in its infancy. So much room for great growth in so many different markets, be it international or sectors.